Aurinia Pharmaceuticals (AUPH) Treasury Shares (2020 - 2026)

Aurinia Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• Quarterly Treasury Shares fell 64.42% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 64.42% YoY) and the FY2025 annual result came in at $4.0 million, down 49.65% from the prior year.
• Treasury Shares was $1.8 million for Q1 2026 at Aurinia Pharmaceuticals, down from $4.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $8.8 million in Q1 2024 and bottomed at $1.8 million in Q1 2026.
• A 5-year average of $5.5 million and a median of $4.9 million in 2025 frame the typical range for Treasury Shares.
• Peak annual rise in Treasury Shares reached 470.61% in 2022, while the deepest fall reached 86.78% in 2022.
• Aurinia Pharmaceuticals' Treasury Shares stood at $2.0 million in 2022, then jumped by 294.29% to $7.8 million in 2023, then climbed by 2.29% to $8.0 million in 2024, then tumbled by 49.65% to $4.0 million in 2025, then plunged by 56.4% to $1.8 million in 2026.
• Business Quant data shows AUPH's Treasury Shares at $1.8 million in Q1 2026, $4.0 million in Q4 2025, and $4.6 million in Q3 2025.